Showing results (51-60 of 260) with videos related to
Sort By:
Pageof 26
Therapeutic Drug Monitoring|March 19, 2014
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperaturesLoretta Franceschi, Piergiorgio Cojutti, Massimo Baraldo, et al.The Journal of Cardiovascular Nursing|July 5, 2012
Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover studyAlvisa Palese, Elena Aidone, Angelo Dante, et al.Drug Design, Development and Therapy|August 11, 2021
Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical NeedsMilo Gatti, Massimo Andreoni, Federico Pea, et al.Antimicrobial Agents and Chemotherapy|October 10, 2012
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approachFederico Pea, Pierluigi Viale, Piergiorgio Cojutti, et al.Clinical Pharmacokinetics|November 22, 2007
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapyFederico Pea, Pierluigi Viale, Federica Pavan, et al.British Journal of Clinical Pharmacology|October 16, 2015
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?Federico Pea, Piergiorgio Cojutti, Lucia Dose, et al.International Journal of Antimicrobial Agents|July 27, 2021
Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosaPier Giorgio Cojutti, Elisa Morandin, Massimo Baraldo, et al.The Journal of Antimicrobial Chemotherapy|September 11, 2019
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional studyPier Giorgio Cojutti, Maria Merelli, Matteo Bassetti, et al.Frontiers in Antibiotics|May 14, 2025
Data transparency and reproducibility in health research: bridging the gap for early-career researchersSanjib Bhakta, Jianping Xie, Federico Pea, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2026
Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysisMilo Gatti, Riccardo De Paola, Beatrice Giorgi, et al.Pageof 26